Gynecologic Cancer News

Researchers at Cancer Care Alberta and University of Calgary have demonstrated the value of a cancer symptom algorithm in correctly identifying which patients may be at high risk for an unplanned ED visit.

Insurance status substantially mediated racial and ethnic inequities among women with advanced-stage cervical cancer, researchers reported in JAMA Network Open.

Doctoral researchers from 11 European institutions and four companies have formed a research network dedicated to developing molecules that stimulate the immune response to tumor cells.

Today marks International Women’s Day.

A phase 2 trial of trastuzumab deruxtecan met a prespecified target for objective response rate and showed clinically meaningful, durable responses across multiple HER2-expressing advanced solid tumors, according to a company press release.

Healio | HemOnc Today is excited to announce the nominees for its second annual Disruptive Innovators Awards in oncology and hematology.

Daily or near daily aspirin use reduced the risk for nonmucinous ovarian cancer across most strata of genetic risk based on a polygenic score, according to a case-control study published in JAMA Network Open.

Rates of past-year screening for breast, cervical and prostate cancer in 2021 remained below prepandemic levels as millions of eligible Americans continued to forgo testing, according to a study published in Journal of Clinical Oncology.

The economic cost of cancer worldwide from 2020 to 2050 will be $25.2 trillion in international dollars, according to results of a decision analytical modeling study published in JAMA Oncology.

SAN FRANCISCO — The newly reignited Cancer Moonshot is centered on the goal to reduce cancer deaths by 50% over the next 25 years.